Inactivation of AKT/NF-κB signaling by eurycomalactone decreases human NSCLC cell viability and improves the chemosensitivity to cisplatin

The high activation of protein kinase B (AKT)/nuclear factor-κB (NF-κB) signaling has often been associated with the induction of non-small cell lung cancer (NSCLC) cell survival and resistance to cisplatin, which is one of the most widely used chemotherapeutic drugs in the treatment of NSCLC. The i...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncol Rep
Main Authors: Dukaew, Nahathai, Chairatvit, Kongthawat, Pitchakarn, Pornsiri, Imsumran, Arisa, Karinchai, Jirarat, Tuntiwechapikul, Wirote, Wongnoppavich, Ariyaphong
Formato: Artigo
Idioma:Inglês
Publicado em: D.A. Spandidos 2020
Assuntos:
Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7448543/
https://ncbi.nlm.nih.gov/pubmed/32945500
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2020.7710
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados